Interne link ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth april 14, 2025 om 11:00 AM UTC
Interne link ProQR Announces Year End 2024 Operating and Financial Results maart 13, 2025 om 11:00 AM UTC
Interne link ProQR Announces R&D Day and Provides Update on Innovation Portfolio november 30, 2015 om 12:00 PM UTC
Interne link ProQR Announces Results for the Third Quarter of 2015 and Provides Update on Clinical Trials november 23, 2015 om 11:30 AM UTC
Interne link ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-010 for Cystic Fibrosis at Two Upcoming Scientific Conferences oktober 01, 2015 om 11:00 AM UTC
Interne link ProQR to Present at the Leerink Partners 4th Annual Rare Disease Roundtable september 23, 2015 om 11:00 AM UTC
Interne link ProQR Announces a Proof-of-Concept Nasal Potential Difference Study of QR-010 is Open for Enrollment september 14, 2015 om 11:00 AM UTC
Interne link ProQR Announces Results for the Second Quarter of 2015 augustus 19, 2015 om 11:59 AM UTC
Interne link ProQR Announces Enrollment Has Started in Global Phase 1b Study of QR-010 in Cystic Fibrosis Patients juni 26, 2015 om 11:54 AM UTC
Interne link ProQR to Present at the JMP Securities Life Science Conference juni 16, 2015 om 11:00 AM UTC
Interne link ProQR Therapeutics Announces Results for the First Quarter of 2015 mei 21, 2015 om 11:00 AM UTC
Interne link ProQR to Present at Two Upcoming Investor Conferences in May april 29, 2015 om 11:00 AM UTC
Interne link ProQR Therapeutics Announces Results for the Fourth Quarter and Full Year 2014 februari 26, 2015 om 12:00 PM UTC
Interne link ProQR to Present at the 2015 Leerink Global Healthcare Conference februari 04, 2015 om 12:00 PM UTC